Top Biotechnology companies in Australia by Return on Assets (ROA)

This ranking features the top 16 Biotechnology companies in Australia ranked by Return on Assets (ROA), averaging a Return on Assets (ROA) of -2.17%, for February 06, 2025.
#
Name
Return on Assets (ROA)
Reported Date
Stock Price
Change
Price (30 days) Country
1
15.42%
June 30, 2024 USD 7.27 0.71%

Australia

2
13.00%
June 30, 2024 USD 195.76 0.28%

Australia

3
9.42%
June 30, 2024 USD 0.74 1.48%

Australia

4
6.95%
June 30, 2024 USD 169.95 -0.56%

Australia

5
4.84%
June 30, 2024 USD 1.23 -0.40%

Australia

6
4.04%
June 30, 2024 USD 2.33 0.08%

Australia

7
3.45%
June 30, 2024 USD 17.72 0.58%

Australia

8
1.31%
Dec. 31, 2023 USD 18.33 -0.84%

Australia

9
-1.28%
June 30, 2024 USD 0.74 0.62%

Australia

10
-8.16%
June 30, 2024 USD 1.90 0.29%

Australia

11
-10.24%
Dec. 31, 2023 USD 1.45 -3.95%

Australia

12
-13.14%
June 30, 2024 USD 1.90 -4.74%

Australia

13
-15.24%
June 30, 2024 USD 2.89 2.85%

Australia

14
-21.19%
June 30, 2024 USD 2.09 0.97%

Australia

15
-21.65%
June 30, 2024 USD 0.87 -0.82%

Australia

16
-147.33%
Dec. 31, 2023 USD 6.16 2.82%

Australia

Frequently Asked Questions
  • Which Biotechnology company in Australia has the highest Return on Assets (ROA) ?

    The Biotechnology company in Australia with the highest Return on Assets (ROA) is Clinuvel Pharmaceuticals Limited (ASX: CUV.AX) at 15.42%.

  • Which Biotechnology company in Australia has the lowest Return on Assets (ROA) ?

    The Biotechnology company in Australia with the lowest Return on Assets (ROA) is Anteris Technologies Ltd (ASX: AVR.AX) at -147.33%.

SV Wall Street